BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $166,703 | $156,471 | $111,389 | $55,640 |
| % Growth | 6.5% | 40.5% | 100.2% | – |
| Cost of Goods Sold | $23,373 | $24,665 | $21,590 | $15,783 |
| Gross Profit | $143,330 | $131,806 | $89,799 | $39,857 |
| % Margin | 86% | 84.2% | 80.6% | 71.6% |
| R&D Expenses | $0 | $0 | $0 | $4,903 |
| G&A Expenses | $0 | $0 | $0 | $58,602 |
| SG&A Expenses | $106,206 | $98,827 | $86,063 | $58,602 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$3 | $4 | -$14 |
| Operating Expenses | $106,206 | $98,827 | $86,063 | $63,505 |
| Operating Income | $37,124 | $32,979 | $3,736 | -$23,648 |
| % Margin | 22.3% | 21.1% | 3.4% | -42.5% |
| Other Income/Exp. Net | -$7,502 | -$7,016 | -$19,036 | -$10,206 |
| Pre-Tax Income | $29,622 | $25,963 | -$15,300 | -$33,854 |
| Tax Expense | -$55,238 | $252 | $5 | $13 |
| Net Income | $84,860 | $25,711 | -$15,305 | -$33,867 |
| % Margin | 50.9% | 16.4% | -13.7% | -60.9% |
| EPS | 0.82 | 0.26 | -0.18 | -0.54 |
| % Growth | 215.4% | 244.4% | 66.7% | – |
| EPS Diluted | 0.82 | 0.24 | -0.18 | -0.54 |
| Weighted Avg Shares Out | 103,293 | 99,831 | 83,214 | 63,165 |
| Weighted Avg Shares Out Dil | 103,293 | 105,063 | 83,214 | 63,165 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7,496 | $7,013 | $19,040 | $10,192 |
| Depreciation & Amortization | $7,424 | $7,516 | $8,831 | $5,897 |
| EBITDA | $44,542 | $40,495 | $12,567 | -$17,765 |
| % Margin | 26.7% | 25.9% | 11.3% | -31.9% |